Trials / Completed
CompletedNCT00946621
To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions
A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability study of Ramipril 10 mg capsules under non-fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramipril 10 mg Capsule (Sandoz) | |
| DRUG | Altace (Ramipril) 10 mg Capsule (Aventis Pharmaceutical) |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2004-11-01
- Completion
- 2004-11-01
- First posted
- 2009-07-27
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00946621. Inclusion in this directory is not an endorsement.